3,571
Views
22
CrossRef citations to date
0
Altmetric
Review

Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1205-1217 | Received 01 Feb 2021, Accepted 31 Mar 2021, Published online: 12 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Manjari Datta, Ashwin Rajeev & Indranil Chattopadhyay. (2023) Application of antimicrobial peptides as next-generation therapeutics in the biomedical world. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-39.
Read now

Articles from other publishers (21)

Yanchao Liu, Youzhuo Zhu, Xin Sun, Tianyue Ma, Xingzhen Lao & Heng Zheng. (2023) DRAVP: A Comprehensive Database of Antiviral Peptides and Proteins. Viruses 15:4, pages 820.
Crossref
Abhishek Chaurasiya, Abhimannu Shome & Pooja A. Chawla. (2023) Molecular docking analysis of peptide-based antiviral agents against SARS-CoV-2 main protease: an approach towards drug repurposing. Exploration of Medicine, pages 33-44.
Crossref
Sara Protić, Nevena Kaličanin, Milan Sencanski, Olivera Prodanović, Jelena Milicevic, Vladimir Perovic, Slobodan Paessler, Radivoje Prodanović & Sanja Glisic. (2023) In Silico and In Vitro Inhibition of SARS-CoV-2 PLpro with Gramicidin D. International Journal of Molecular Sciences 24:3, pages 1955.
Crossref
Anjali Jayasree Balakrishnan, Aswathi Kodenchery Somasundaran, Prajit Janardhanan & Rajendra Pilankatta. 2023. Antimicrobial Peptides. Antimicrobial Peptides 219 235 .
Kansate Prasertsuk, Kasidit Prongfa, Piyapach Suttiwanich, Nathaphat Harnkit, Mattanun Sangkhawasi, Pongsakorn Promta & Pramote Chumnanpuen. (2022) Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome. Molecules 28:1, pages 50.
Crossref
Hamid Madanchi, Saman Rahmati, Yeganeh Doaei, Soroush Sardari, Masoumeh Sadat Mousavi Maleki, Mosayeb Rostamian, Ramin Ebrahimi Kiasari, Seyed Javad Seyed Mousavi, Elahe Ghods & Maryam Ardekanian. (2022) Determination of antifungal activity and action mechanism of the modified Aurein 1.2 peptide derivatives. Microbial Pathogenesis 173, pages 105866.
Crossref
Masoumeh Sadat Mousavi Maleki, Soroush Sardari, Ali Ghandehari Alavijeh & Hamid Madanchi. (2022) Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals. International Journal of Peptide Research and Therapeutics 29:1.
Crossref
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, Yalda Yazdani, Omid Gholizadeh, Raheleh Tabatabaie, Hamed Afkhami, Fatemeh Davodabadi, Alireza Khanalipour farkhad, Daryoush Pahlevan, Akram Firouzi-Amandi, Kazem Nejati-Koshki & Mehdi Dadashpour. (2022) An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. Journal of Nanobiotechnology 20:1.
Crossref
Dalia Mamdouh Mabrouk. (2022) Antimicrobial peptides: features, applications and the potential use against covid-19. Molecular Biology Reports 49:10, pages 10039-10050.
Crossref
G. Moroy & P. Tuffery. (2022) Peptide-Based Strategies Against SARS-CoV-2 Attack: An Updated In Silico Perspective. Frontiers in Drug Discovery 2.
Crossref
Pritam V. Bagwe, Priyal V. Bagwe, Sai Srinivas Ponugoti & Shreerang V. Joshi. (2022) Peptide-Based Vaccines and Therapeutics for COVID-19. International Journal of Peptide Research and Therapeutics 28:3.
Crossref
Xin Li, Siyao Zuo, Bin Wang, Kaiyu Zhang & Yang Wang. (2022) Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides. Molecules 27:9, pages 2675.
Crossref
Linda Sukmarini. (2022) Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses. Molecules 27:9, pages 2619.
Crossref
Lei Wang, Linkai Qu, Sue Lin, Qinsi Yang, Xingxing Zhang, Libo Jin, Hao Dong & Da Sun. (2022) Biological Functions and Applications of Antimicrobial Peptides. Current Protein & Peptide Science 23:4, pages 226-247.
Crossref
Sheetal Sharma, Panchali Barman, Shubhi Joshi, Simran Preet & Avneet Saini. (2022) Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics. Colloids and Surfaces B: Biointerfaces 211, pages 112303.
Crossref
Marialaura Scarcella, Emidio Scarpellini, Alessandra Ascani, Rita Commissari, Claudia Scorcella, Michela Zanetti, Amilcare Parisi, Riccardo Monti, Natasa Milic, Abele Donati, Francesco Luzza, Edoardo De Robertis & Ludovico Abenavoli. (2022) Effect of Whey Proteins on Malnutrition and Extubating Time of Critically Ill COVID-19 Patients. Nutrients 14:3, pages 437.
Crossref
Anqi Wang, Yuan Zheng, Wanxin Zhu, Liuxin Yang, Yang Yang & Jinliang Peng. (2022) Melittin-Based Nano-Delivery Systems for Cancer Therapy. Biomolecules 12:1, pages 118.
Crossref
Jhih-Hua Jhong, Lantian Yao, Yuxuan Pang, Zhongyan Li, Chia-Ru Chung, Rulan Wang, Shangfu Li, Wenshuo Li, Mengqi Luo, Renfei Ma, Yuqi Huang, Xiaoning Zhu, Jiahong Zhang, Hexiang Feng, Qifan Cheng, Chunxuan Wang, Kun Xi, Li-Ching Wu, Tzu-Hao Chang, Jorng-Tzong Horng, Lizhe Zhu, Ying-Chih Chiang, Zhuo Wang & Tzong-Yi Lee. (2022) dbAMP 2.0: updated resource for antimicrobial peptides with an enhanced scanning method for genomic and proteomic data. Nucleic Acids Research 50:D1, pages D460-D470.
Crossref
Noor T. Al-Bayatee & Ali H. Ad'hiah. (2021) Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19. Microbial Pathogenesis 160, pages 105205.
Crossref
Maya Madhavan, Lamya A. AlOmair, Deepthi KS & Sabeena Mustafa. (2021) Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19. Journal of Infection and Public Health 14:8, pages 1106-1119.
Crossref
Bin Gao & Shunyi Zhu. (2021) A Fungal Defensin Targets the SARS−CoV−2 Spike Receptor−Binding Domain. Journal of Fungi 7:7, pages 553.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.